Immunotherapies will continue to change standards of care for treatment of RCC.
Kirollos Hanna, PharmD, BCPS, BCOP; Ashley Barlow, PharmD; and Brooke Barlow, Pharm D
Advertisement
Articles by Kirollos Hanna, PharmD, BCPS, BCOP; Ashley Barlow, PharmD; and Brooke Barlow, Pharm D
Advertisement
Latest Updated Articles
Updates in Renal Cell Carcinoma ManagementPublished: April 22nd 2021 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
A Review of Antibody-Drug Conjugates for the Treatment of Urothelial Carcinoma: The Rise of Enfortumab Vedotin
2
Oral Semaglutide Shows Promise for Weight Loss and Cardiometabolic Health
3
MFN, DTC, and the Policy Pressure Cooker: Reshaping the US Drug Market
4
Interim Phase 2 IOV-LUNG-202 Data Show Lifileucel’s Potential Treating Advanced NSCLC
5
